搜索结果：Current diabetes reports

Artificial intelligence (AI) algorithms are a critical part of state-of-the-art digital health technology for diabetes management. Yet, access to large high-quality datasets is creating barriers that impede development of robust AI solutions. To accelerate development of transparent, reproducible, and robust AI solutions, we present Glucose-ML, a collection of 10 publicly available diabetes datasets, released within the last 7 years (i.e., 2018 - 2025). The Glucose-ML collection comprises over 300,000 days of continuous glucose monitor (CGM) data with a total of 38 million glucose samples collected from 2500+ people across 4 countries. Participants include persons living with type 1 diabetes, type 2 diabetes, prediabetes, and no diabetes. To support researchers and innovators with using this rich collection of diabetes datasets, we present a comparative analysis to guide algorithm developers with data selection. Additionally, we conduct a case study for the task of blood glucose prediction - one of the most common AI tasks within the field. Through this case study, we provide a benchmark for short-term blood glucose prediction across all 10 publicly available diabetes datasets with

Diabetes devices, including Continuous Glucose Monitoring (CGM), Smart Insulin Pens, and Automated Insulin Delivery systems, generate rich time-series data widely used in research and machine learning. However, inconsistent data formats across sources hinder sharing, integration, and analysis. We present DIAX (DIAbetes eXchange), a standardized JSON-based format for unifying diabetes time-series data, including CGM, insulin, and meal signals. DIAX promotes interoperability, reproducibility, and extensibility, particularly for machine learning applications. An open-source repository provides tools for dataset conversion, cross-format compatibility, visualization, and community contributions. DIAX is a translational resource, not a data host, ensuring flexibility without imposing data-sharing constraints. Currently, DIAX is compatible with other standardization efforts and supports major datasets (DCLP3, DCLP5, IOBP2, PEDAP, T1Dexi, Loop), totaling over 10 million patient-hours of data. https://github.com/Center-for-Diabetes-Technology/DIAX

Diabetes is a chronic disease with a significant global health burden, requiring multi-stakeholder collaboration for optimal management. Large language models (LLMs) have shown promise in various healthcare scenarios, but their effectiveness across diverse diabetes tasks remains unproven. Our study introduced a framework to train and validate diabetes-specific LLMs. We first developed a comprehensive data processing pipeline that includes data collection, filtering, augmentation and refinement. This created a high-quality, diabetes-specific dataset and evaluation benchmarks from scratch. Fine-tuned on the collected training dataset, our diabetes-specific LLM family demonstrated state-of-the-art proficiency in processing various diabetes tasks compared to other LLMs. Furthermore, clinical studies revealed the potential applications of our models in diabetes care, including providing personalized healthcare, assisting medical education, and streamlining clinical tasks. Generally, our introduced framework helps develop diabetes-specific LLMs and highlights their potential to enhance clinical practice and provide personalized, data-driven support for diabetes management across differen

Diabetes has emerged as a significant global health issue, especially with the increasing number of cases in many countries. This trend Underlines the need for a greater emphasis on early detection and proactive management to avert or mitigate the severe health complications of this disease. Over recent years, machine learning algorithms have shown promising potential in predicting diabetes risk and are beneficial for practitioners. Objective: This study highlights the prediction capabilities of statistical and non-statistical machine learning methods over Diabetes risk classification in 768 samples from the Pima Indians Diabetes Database. It consists of the significant demographic and clinical features of age, body mass index (BMI) and blood glucose levels that greatly depend on the vulnerability against Diabetes. The experimentation assesses the various types of machine learning algorithms in terms of accuracy and effectiveness regarding diabetes prediction. These algorithms include Logistic Regression, Decision Tree, Random Forest, K-Nearest Neighbors, Naive Bayes, Support Vector Machine, Gradient Boosting and Neural Network Models. The results show that the Neural Network algor

Understanding the complex relationships of biomarkers in diabetes is pivotal for advancing treatment strategies, a pressing need in diabetes research. This study applies Bayesian network structure learning to analyze the Shanghai Type 1 and Type 2 diabetes mellitus datasets, revealing complex relationships among key diabetes-related biomarkers. The constructed Bayesian network presented notable predictive accuracy, particularly for Type 2 diabetes mellitus, with root mean squared error (RMSE) of 18.23 mg/dL, as validated through leave-one-domain experiments and Clarke error grid analysis. This study not only elucidates the intricate dynamics of diabetes through a deeper understanding of biomarker interplay but also underscores the significant potential of integrating data-driven and knowledge-driven methodologies in the realm of personalized diabetes management. Such an approach paves the way for more custom and effective treatment strategies, marking a notable advancement in the field.

Class imbalance remains a practical obstacle in the development of clinical prediction models for conditions such as diabetes mellitus, where the number of confirmed cases is often much smaller than the number of controls. The Synthetic Minority Over-sampling Technique (SMOTE) and its variants are widely used to address this imbalance, but they generate synthetic observations through local interpolation in feature space and do not explicitly model the joint dependence structure of the minority class. To address this challenge, our study introduces a copula-based data augmentation approach that estimates the minority-class dependence structure when generating synthetic samples and integrates with standard machine learning techniques. Specifically, we employ truncated vine copulas to represent multivariate dependence through a sequence of bivariate building blocks. We evaluate the proposed approach on three public diabetes datasets, namely the Pima Indians Diabetes dataset, the Iraqi Diabetes dataset, and the CDC BRFSS 2015 Diabetes Health Indicators dataset, which together cover a range of sample sizes, dimensionalities, and imbalance regimes. For each dataset, five resampling strat

In many nations, diabetes is becoming a significant health problem, and early identification and control are crucial. Using machine learning algorithms to predict diabetes has yielded encouraging results. Using the Pima Indians Diabetes dataset, this study attempts to evaluate the efficacy of several machine-learning methods for diabetes prediction. The collection includes information on 768 patients, such as their ages, BMIs, and glucose levels. The techniques assessed are Logistic Regression, Decision Tree, Random Forest, k-Nearest Neighbors, Naive Bayes, Support Vector Machine, Gradient Boosting, and Neural Network. The findings indicate that the Neural Network algorithm performed the best, with an accuracy of 78.57 percent, followed by the Random Forest method, with an accuracy of 76.30 percent. The study implies that machine learning algorithms can aid diabetes prediction and be an efficient early detection tool.

This review explores the synthesis, characterization, and therapeutic applications of zinc oxide nanoparticles (ZnO NPs) in the treatment of diabetes mellitus. The study delves into both chemical and green synthesis methods, comparing their impacts on nanoparticle properties. Key characterization techniques such as XRD, FTIR, UV-Vis spectroscopy, and SEM confirm the crystalline structure, optical properties, and morphology of the nanoparticles. ZnO NPs demonstrate significant biological activities, including antibacterial, anti-inflammatory, and antidiabetic effects. These nanoparticles show promise in improving glucose regulation, enhancing insulin sensitivity, and boosting glucose uptake in cells. Despite these benefits, the potential toxicity and long-term effects of ZnO NPs warrant further investigation. Future research should focus on optimizing synthesis methods and conducting comprehensive studies to fully exploit ZnO NPs' potential in diabetes management and other biomedical applications.

With the continuous development and improvement of medical services, there is a growing demand for improving diabetes diagnosis. Exhaled breath analysis, characterized by its speed, convenience, and non-invasive nature, is leading the trend in diagnostic development. Studies have shown that the acetone levels in the breath of diabetes patients are higher than normal, making acetone a basis for diabetes breath analysis. This provides a more readily accepted method for early diabetes prevention and monitoring. Addressing issues such as the invasive nature, disease transmission risks, and complexity of diabetes testing, this study aims to design a diabetes gas biomarker acetone detection system centered around a sensor array using gas sensors and pattern recognition algorithms. The research covers sensor selection, sensor preparation, circuit design, data acquisition and processing, and detection model establishment to accurately identify acetone. Titanium dioxide was chosen as the nano gas-sensitive material to prepare the acetone gas sensor, with data collection conducted using STM32. Filtering was applied to process the raw sensor data, followed by feature extraction using principa

In this study, we delve into the intricate relationships between diabetes and a range of health indicators, with a particular focus on the newly added variable of income. Utilizing data from the 2015 Behavioral Risk Factor Surveillance System (BRFSS), we analyze the impact of various factors such as blood pressure, cholesterol, BMI, smoking habits, and more on the prevalence of diabetes. Our comprehensive analysis not only investigates each factor in isolation but also explores their interdependencies and collective influence on diabetes. A novel aspect of our research is the examination of income as a determinant of diabetes risk, which to the best of our knowledge has been relatively underexplored in previous studies. We employ statistical and machine learning techniques to unravel the complex interplay between socio-economic status and diabetes, providing new insights into how financial well-being influences health outcomes. Our research reveals a discernible trend where lower income brackets are associated with a higher incidence of diabetes. In analyzing a blend of 33 variables, including health factors and lifestyle choices, we identified that features such as high blood pres

Diabetes, resulting from inadequate insulin production or utilization, causes extensive harm to the body. Existing diagnostic methods are often invasive and come with drawbacks, such as cost constraints. Although there are machine learning models like Classwise k Nearest Neighbor (CkNN) and General Regression Neural Network (GRNN), they struggle with imbalanced data and result in under-performance. Leveraging advancements in sensor technology and machine learning, we propose a non-invasive diabetes diagnosis using a Back Propagation Neural Network (BPNN) with batch normalization, incorporating data re-sampling and normalization for class balancing. Our method addresses existing challenges such as limited performance associated with traditional machine learning. Experimental results on three datasets show significant improvements in overall accuracy, sensitivity, and specificity compared to traditional methods. Notably, we achieve accuracies of 89.81% in Pima diabetes dataset, 75.49% in CDC BRFSS2015 dataset, and 95.28% in Mesra Diabetes dataset. This underscores the potential of deep learning models for robust diabetes diagnosis. See project website https://steve-zeyu-zhang.github.

Purpose: We investigated the utilization of privacy-preserving, locally-deployed, open-source Large Language Models (LLMs) to extract diagnostic information from free-text cardiovascular magnetic resonance (CMR) reports. Materials and Methods: We evaluated nine open-source LLMs on their ability to identify diagnoses and classify patients into various cardiac diagnostic categories based on descriptive findings in 109 clinical CMR reports. Performance was quantified using standard classification metrics including accuracy, precision, recall, and F1 score. We also employed confusion matrices to examine patterns of misclassification across models. Results: Most open-source LLMs demonstrated exceptional performance in classifying reports into different diagnostic categories. Google's Gemma2 model achieved the highest average F1 score of 0.98, followed by Qwen2.5:32B and DeepseekR1-32B with F1 scores of 0.96 and 0.95, respectively. All other evaluated models attained average scores above 0.93, with Mistral and DeepseekR1-7B being the only exceptions. The top four LLMs outperformed our board-certified cardiologist (F1 score of 0.94) across all evaluation metrics in analyzing CMR reports.

The Quantum-Inspired Stacked Integrated Concept Graph Model (QISICGM) is an innovative machine learning framework that harnesses quantum-inspired techniques to predict diabetes risk with exceptional accuracy and efficiency. Utilizing the PIMA Indians Diabetes dataset augmented with 2,000 synthetic samples to mitigate class imbalance (total: 2,768 samples, 1,949 positives), QISICGM integrates a self-improving concept graph with a stacked ensemble comprising Random Forests (RF), Extra Trees (ET), transformers, convolutional neural networks (CNNs), and feed-forward neural networks (FFNNs). This approach achieves an out-of-fold (OOF) F1 score of 0.8933 and an AUC of 0.8699, outperforming traditional methods. Quantum inspired elements, such as phase feature mapping and neighborhood sequence modeling, enrich feature representations, enabling CPU-efficient inference at 8.5 rows per second. This paper presents a detailed architecture, theoretical foundations, code insights, and performance evaluations, including visualizations from the outputs subfolder. The open-source implementation (v1.0.0) is available at https://github.com/keninayoung/QISICGM, positioning QISICGM as a potential benchm

The paper investigates the escalating concerns surrounding the surge in diabetes cases, exacerbated by the COVID-19 pandemic, and the subsequent strain on medical resources. The research aims to construct a predictive model quantifying factors influencing inpatient hospital stay durations for diabetes patients, offering insights to hospital administrators for improved patient management strategies. The literature review highlights the increasing prevalence of diabetes, emphasizing the need for continued attention and analysis of urban-rural disparities in healthcare access. International studies underscore the financial implications and healthcare burden associated with diabetes-related hospitalizations and complications, emphasizing the significance of effective management strategies. The methodology involves a quantitative approach, utilizing a dataset comprising 10,000 observations of diabetic inpatient encounters in U.S. hospitals from 1999 to 2008. Predictive modeling techniques, particularly Generalized Linear Models (GLM), are employed to develop a model predicting hospital stay durations based on patient demographics, admission types, medical history, and treatment regimen.

Climate change is intensifying infectious and chronic diseases like malaria and diabetes, respectively, especially among the vulnerable populations. Global temperatures have risen by approximately $0.6^\circ$C since 1950, extending the window of transmission for mosquito-borne infections and worsening outcomes in diabetes due to metabolic stress caused by heat. People living with diabetes have already weakened immune defenses and, therefore, are at an alarmingly increased risk of contraction of malaria. However, most models rarely include both ways of interaction in changing climate conditions. In the paper, we introduce a new compartmental epidemiological model based on synthetic data fitted to disease patterns of India from 2019 to 2021. The framework captures temperature-dependent transmission parameters, seasonal variability, and different disease dynamics between diabetic and non-diabetic groups within the three-compartment system. Model calibration using Multi-Start optimization combined with Sequential Quadratic Programming allows us to find outstanding differences between populations. The odds of malaria infection in diabetic individuals were found to be 1.8--4.0 times high

Type 2 Diabetes is one of the most major and fatal diseases known to human beings, where thousands of people are subjected to the onset of Type 2 Diabetes every year. However, the diagnosis and prevention of Type 2 Diabetes are relatively costly in today's scenario; hence, the use of machine learning and deep learning techniques is gaining momentum for predicting the onset of Type 2 Diabetes. This research aims to increase the accuracy and Area Under the Curve (AUC) metric while improving the processing time for predicting the onset of Type 2 Diabetes. The proposed system consists of a deep learning technique that uses the Support Vector Machine (SVM) algorithm along with the Radial Base Function (RBF) along with the Long Short-term Memory Layer (LSTM) for prediction of onset of Type 2 Diabetes. The proposed solution provides an average accuracy of 86.31 % and an average AUC value of 0.8270 or 82.70 %, with an improvement of 3.8 milliseconds in the processing. Radial Base Function (RBF) kernel and the LSTM layer enhance the prediction accuracy and AUC metric from the current industry standard, making it more feasible for practical use without compromising the processing time.

Effective diabetes management is crucial for maintaining health in diabetic patients. Large Language Models (LLMs) have opened new avenues for diabetes management, facilitating their efficacy. However, current LLM-based approaches are limited by their dependence on general sources and lack of integration with domain-specific knowledge, leading to inaccurate responses. In this paper, we propose a knowledge-infused LLM-powered conversational health agent (CHA) for diabetic patients. We customize and leverage the open-source openCHA framework, enhancing our CHA with external knowledge and analytical capabilities. This integration involves two key components: 1) incorporating the American Diabetes Association dietary guidelines and the Nutritionix information and 2) deploying analytical tools that enable nutritional intake calculation and comparison with the guidelines. We compare the proposed CHA with GPT4. Our evaluation includes 100 diabetes-related questions on daily meal choices and assessing the potential risks associated with the suggested diet. Our findings show that the proposed agent demonstrates superior performance in generating responses to manage essential nutrients.

Single gene mutations have been implicated in the pathogenesis of a form of diabetes mellitus (DM) known as the maturity-onset diabetes of the young (MODY). However, there are diverse opinions on the suspect genes and pathophysiology, necessitating the need to review and communicate the genes to raise public awareness. We used the Google search engine to retrieve relevant information from reputable sources such as PubMed and Google Scholar. We identified 14 classified MODY genes as well as three new and unclassified genes linked with MODY. These genes are fundamentally embedded in the beta cells, the most common of which are HNF1A, HNF4A, HNF1B, and GCK genes. Mutations in these genes cause beta-cell dysfunction, resulting in decreased insulin production and hyperglycemia. MODY genes have distinct mechanisms of action and phenotypic presentations compared with type 1 and type 2 DM and other forms of DM. Healthcare professionals are therefore advised to formulate drugs and treatment based on the causal genes rather than the current generalized treatment for all types of DM. This will increase the effectiveness of diabetes drugs and treatment and reduce the burden of the disease.

Clinical practice guidelines are designed to guide clinical practice and involve causal language. Sometimes guidelines make or require stronger causal claims than those in the references they rely on, a phenomenon we refer to as 'causal language jump'. We evaluated the strength of expressed causation in diabetes guidelines and the evidence they reference to assess the pattern of jumps. We randomly sampled 300 guideline statements from four diabetes guidelines. We rated the causation strength in the statements and the dependence on causation in recommendations supported by these statements using existing scales. Among the causal statements, the cited original studies were similarly assessed. We also assessed how well they report target trial emulation (TTE) components as a proxy for reliability. Of the sampled statements, 114 (38.0%) were causal, and 76 (66.7%) expressed strong causation. 27.2% (31/114) of causal guideline statements demonstrated a "causal language jump", and 34.9% (29/83) of guideline recommendations cannot be effectively supported. Of the 53 eligible studies for TTE rating, most did not report treatment assignment and causal contrast in detail. Our findings sugges